U-Blot® Research Grade Anti-Human CLDN6 Antibody (AB3-7)Cat. No. WA1840Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CLDN6 Antibody (AB3-7)Cat. No. WA1840
U-Blot® Research Grade Anti-Human CLDN6 Antibody (AB1-11)Cat. No. WA1839
U-Blot® Research Grade Anti-Human CLDN6 Antibody (64A)Cat. No. WA1838
U-Blot® Research Grade Anti-Human CLDN6 (IMAB-027)Cat. No. WA1837
U-Blot® Research Grade Anti-Human CLDN6 (AMG 794)Cat. No. WA1836
U-Blot® Research Grade Anti-Human CLDN6 & CD3 Antibody (6PHU3)Cat. No. WA1835
U-Blot® Research Grade Anti-Human CLDN6 & CD137 Bispecific Antibody (NBL-028)Cat. No. WA1834
U-Blot® Research Grade Anti-Human CLDN18.2 (TST001)Cat. No. WA1833
U-Blot® Research Grade Anti-Human CLDN18.2 (SYSA1801)Cat. No. WA1832
U-Blot® Research Grade Anti-Human CLDN18.2 (SPX-101)Cat. No. WA1831
U-Blot® Research Grade Anti-Human CLDN18.2 (SKB315)Cat. No. WA1830
U-Blot® Research Grade Anti-Human CLDN18.2 (RC118)Cat. No. WA1829